Skip to main content
Lunai Bioworks Inc. logo

Lunai Bioworks Inc. — Investor Relations & Filings

Ticker · RENB ISIN · US29350E1047 US Professional, scientific and technical activities
Filings indexed 580 across all filing types
Latest filing 2022-05-13 Interim / Quarterly Rep…
Country US United States of America
Listing US RENB

About Lunai Bioworks Inc.

https://www.lunaibio.com

Lunai Bioworks Inc. is a pre-clinical stage biotechnology company that utilizes artificial intelligence for drug discovery and biodefense. The company focuses on pioneering safe and responsible generative biology to develop new therapies. By harnessing phenomics and AI, it aims to decode disease signals and translate them into treatments. Its proprietary Transformer Platform is designed to accelerate drug discovery processes. Lunai Bioworks develops medicines, diagnostics, and biodefense products, with a pipeline that includes programs for neurodegenerative conditions like Alzheimer's disease.

Recent filings

Filing Released Lang Actions
FORM 10-Q
Interim / Quarterly Report Q3 2022
2022-05-13 English
FORM 8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The content specifically announces the hiring of a new Executive Vice President of Research and Development. There are no financial statements or detailed financial data included. The document is relatively short (3543 characters) and serves as a regulatory announcement of a management change rather than a full report or detailed financial disclosure. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of changes in senior management.
2022-04-20 English
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated April 7, 2022, for Enochian Biosciences Inc. The content describes the hiring of a new Senior Vice President for Clinical Operations and includes a press release as an exhibit. There are no financial statements, earnings data, or detailed management discussion. The document is a current report announcing a material event (management change). This fits the category of Board/Management Information (MANG), which covers announcements of changes in senior management. The document length is 3501 characters, which is short and focused on a management appointment, not a full report or earnings release.
2022-04-07 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce unscheduled material events or corporate changes. The content describes a press release about a plenary lecture delivered by a company executive, which is furnished as an exhibit. There are no financial statements, earnings data, or detailed financial analysis present. The document is short (3541 characters) and primarily serves as a notification of an event rather than a detailed report. Therefore, it does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is a regulatory filing reporting a current event, so the appropriate classification is Regulatory Filings (RNS).
2022-04-05 English
FORM 8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated March 25, 2022, reporting the resignation of a board member, Carl Sandler. The key content is about a change in the company's board of directors. There are no financial statements or detailed financial data present. The document is focused on management/board changes, which fits the category of Board/Management Information (MANG). The document length is 3131 characters, which is short and consistent with a typical 8-K filing for management changes. Therefore, the classification is MANG with high confidence.
2022-03-29 English
Director's Dealing 2022
Director's Dealing
2022-03-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.